Article
Quantification of acetaldehyde and carbon dioxide in the headspace of malignant and non-malignant lung cells in vitro by SIFT-MS.
Institute for Science and Technology in Medicine, School of Medicine, Keele University, Thornburrow Drive, Hartshill, Stoke-on-Trent, ST4 7QB, UK.
The Analyst (impact factor:
4.23).
12/2009;
134(12):2419-25.
DOI:10.1039/b916158a
pp.2419-25
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: The clinical potential of exhaled breath analysis for diabetes mellitus.
[show abstract] [hide abstract]
ABSTRACT: Various compounds in present human breath have long been loosely associated with pathological states (including acetone smell in uncontrolled diabetes). Only recently, however, the precise measurement of exhaled volatile organic compounds (VOCs) and aerosolized particles was made possible at extremely low concentrations by advances in several analytical methodologies, described in detail in the international literature and each suitable for specific subsets of exhaled compounds. Exhaled gases may be generated endogenously (in the pulmonary tract, blood, or peripheral tissues), as metabolic by-products of human cells or colonizing micro-organisms, or may be inhaled as atmospheric pollutants; growing evidence indicates that several of these molecules have distinct cell-to-cell signaling functions. Independent of origin and physiological role, exhaled VOCs are attractive candidates as biomarkers of cellular activity/metabolism, and could be incorporated in future non-invasive clinical testing devices. Indeed, several recent studies reported altered exhaled gas profiles in dysmetabolic conditions and relatively accurate predictions of glucose concentrations, at least in controlled experimental conditions, for healthy and diabetic subjects over a broad range of glycemic values. Optimization of this methodology and validation in large-scale trials under a wider range of conditions is needed to determine its true potential to transition into practical clinical use.Diabetes research and clinical practice 03/2012; 97(2):195-205. · 2.16 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
35FL121 Tel+ telomerase positive lung fibroblast cells
acetone
CALU-1
carbon dioxide
cell culture medium
cell numbers
cell type
conflicting results
culture medium
foetal calf serum
headspace
incubation
ion flow tube mass spectrometry
NL20 cell cultures
NL20 cells
NL20 normal lung epithelial cells
Previous studies
SIFT-MS studies
three compounds
two culture media